SUMMARY ATI PHARMACOLOGY 2024
Psychosocial Integrity: - (ANSWERS)
Substance Use Disorder: Priority Teaching for Varenicline - (ANSWERS)-Instruct client to take
medication after a meal
-Monitor blood pressure during treatment
-Monitor clients who have diabetes mellitus for loss of glycemic control
-Follow instructions for titration to minimize adverse effects
-Advise client to notify the provider if nausea, vomiting, insomnia, new-onset depression, or suicidal
thoughts occur.
-Can cause neuropsychiatric effects such as unpredictable behavior, mood changes, and thoughts of
suicide
-Due to potential adverse effects, varenicline is banned for use in clients who are commercial truck or
bus drivers, air traffic controllers, or airplane pilot
Ch. 12
Adverse Effects/
Contraindications/
Side Effects/ Interactions: - (ANSWERS)
Depressive DO: Adverse Effect of Sertraline - (ANSWERS)-Sexual dysfunction (anorgasmia, impotence,
decreased libio)
-CNS stimulation (inability to sleep, agitation, anxiety)
-Weight loss early in therapy
-Serotonin syndrome (mental confusion, fever, tachycardia, increasedbp, abdominal pain,
diaphoresis, tremors, seizures etc)
Ch. 8
Coagulation Meds: Lab Values to Report to Provider - (ANSWERS)-aPTT alue 1.5-2 times baseline
(normal)
-Decreased platelet count
Ch. 25
, Antibiotics Affecting Cell Wall: Plan of care for client administered antibiotics - (ANSWERS)-Take meds
with meals
-Report any signs of allergy
-Give IM to avoid injecting in nerve or artery
-Complete entire course of treatment
-Use additional contraceptive measures
Ch. 44
Chemotherapy Agents: Monitoring for Toxicity - (ANSWERS)-Monitor Liver enzymes
-monitor for signs of jaundice
-Monitor for bleeding (coffee ground emesis or stools)
-Assess mouth for sores
-Contraceptive use
-Monitor for signs of neurotoxicity (such as nystagmus)
Ch. 42
Administration of Heparin - (ANSWERS)-Obtain baseline vital signs
-Obtain baseline and monitor complete blood count (CBC), platelet count, and hematocrit levels
-Read label carefully. Heparin is dispensed in units and in a variety of concentrations
-Check dosages with another nurse before administration
-Use an infusion pump for continuous IV administration. Monitor rate of infusion every 30 to 60 min
-Monitor aPTT every 4 to 6 hr until appropriate dose is determined, then monitor daily
-For subcutaneous injections, use a 20- to 22-gauge needle to withdraw medication from the vial.
Then, change the needle to a smaller needle (25- or 26-gauge, ½ to ⅝ inches long)
-Administer deep subcutaneous injections in the abdomen, ensuring a distance of 2 inches from the
umbilicus. Do not aspirate
-Apply gentle pressure for 1 to 2 min after the injection. Rotate and record injection sites
-Instruct clients to monitor for indications of bleeding: bruising, gums bleeding, abdominal pain, nose
bleeds, coffee-ground emesis, and tarry stools
-Instruct clients to avoid the use of over-the-counter (OTC) NSAIDs, aspirin, or medications containing
salicylates.
Ch. 25
Psychosocial Integrity: - (ANSWERS)
Substance Use Disorder: Priority Teaching for Varenicline - (ANSWERS)-Instruct client to take
medication after a meal
-Monitor blood pressure during treatment
-Monitor clients who have diabetes mellitus for loss of glycemic control
-Follow instructions for titration to minimize adverse effects
-Advise client to notify the provider if nausea, vomiting, insomnia, new-onset depression, or suicidal
thoughts occur.
-Can cause neuropsychiatric effects such as unpredictable behavior, mood changes, and thoughts of
suicide
-Due to potential adverse effects, varenicline is banned for use in clients who are commercial truck or
bus drivers, air traffic controllers, or airplane pilot
Ch. 12
Adverse Effects/
Contraindications/
Side Effects/ Interactions: - (ANSWERS)
Depressive DO: Adverse Effect of Sertraline - (ANSWERS)-Sexual dysfunction (anorgasmia, impotence,
decreased libio)
-CNS stimulation (inability to sleep, agitation, anxiety)
-Weight loss early in therapy
-Serotonin syndrome (mental confusion, fever, tachycardia, increasedbp, abdominal pain,
diaphoresis, tremors, seizures etc)
Ch. 8
Coagulation Meds: Lab Values to Report to Provider - (ANSWERS)-aPTT alue 1.5-2 times baseline
(normal)
-Decreased platelet count
Ch. 25
, Antibiotics Affecting Cell Wall: Plan of care for client administered antibiotics - (ANSWERS)-Take meds
with meals
-Report any signs of allergy
-Give IM to avoid injecting in nerve or artery
-Complete entire course of treatment
-Use additional contraceptive measures
Ch. 44
Chemotherapy Agents: Monitoring for Toxicity - (ANSWERS)-Monitor Liver enzymes
-monitor for signs of jaundice
-Monitor for bleeding (coffee ground emesis or stools)
-Assess mouth for sores
-Contraceptive use
-Monitor for signs of neurotoxicity (such as nystagmus)
Ch. 42
Administration of Heparin - (ANSWERS)-Obtain baseline vital signs
-Obtain baseline and monitor complete blood count (CBC), platelet count, and hematocrit levels
-Read label carefully. Heparin is dispensed in units and in a variety of concentrations
-Check dosages with another nurse before administration
-Use an infusion pump for continuous IV administration. Monitor rate of infusion every 30 to 60 min
-Monitor aPTT every 4 to 6 hr until appropriate dose is determined, then monitor daily
-For subcutaneous injections, use a 20- to 22-gauge needle to withdraw medication from the vial.
Then, change the needle to a smaller needle (25- or 26-gauge, ½ to ⅝ inches long)
-Administer deep subcutaneous injections in the abdomen, ensuring a distance of 2 inches from the
umbilicus. Do not aspirate
-Apply gentle pressure for 1 to 2 min after the injection. Rotate and record injection sites
-Instruct clients to monitor for indications of bleeding: bruising, gums bleeding, abdominal pain, nose
bleeds, coffee-ground emesis, and tarry stools
-Instruct clients to avoid the use of over-the-counter (OTC) NSAIDs, aspirin, or medications containing
salicylates.
Ch. 25
